IsoRay, Inc. (NYSEAMERICAN:ISR) saw unusually-high trading volume on Wednesday . Approximately 3,194,182 shares were traded during mid-day trading, an increase of 364% from the previous session’s volume of 688,253 shares.The stock last traded at $0.59 and had previously closed at $0.51.
Separately, HC Wainwright began coverage on IsoRay in a research report on Monday, August 20th. They issued a “neutral” rating and a $1.00 price objective on the stock.
IsoRay Company Profile (NYSEAMERICAN:ISR)
IsoRay, Inc, through its subsidiary, IsoRay Medical, Inc, develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States. The company produces CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers, as well as ocular melanoma.
Featured Article: Google Finance Portfolio
Receive News & Ratings for IsoRay Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IsoRay and related companies with MarketBeat.com's FREE daily email newsletter.